The second and third most highly quoted studies explored molecular mechanism of the anti-EGFR and chemotherapeutic drug resistance in CRC, which were published in Nature (IF=49.96) and Cell Stem Cell (IF=24.63), respectively. Here, EGFR is linked to colorectal carcinoma.